ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 56 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $23,000 | -23.3% | 108,916 | +5.6% | 0.00% | – |
| Q1 2022 | $30,000 | -79.3% | 103,159 | -60.4% | 0.00% | – |
| Q4 2021 | $145,000 | +23.9% | 260,276 | +125.7% | 0.00% | – |
| Q3 2021 | $117,000 | -10.7% | 115,309 | +21.2% | 0.00% | – |
| Q2 2021 | $131,000 | -41.5% | 95,175 | -28.0% | 0.00% | – |
| Q1 2021 | $224,000 | +62.3% | 132,215 | +19.2% | 0.00% | – |
| Q4 2020 | $138,000 | +62.4% | 110,891 | +84.6% | 0.00% | – |
| Q3 2020 | $85,000 | +63.5% | 60,067 | +37.9% | 0.00% | – |
| Q2 2020 | $52,000 | -67.1% | 43,562 | -67.3% | 0.00% | – |
| Q1 2020 | $158,000 | -30.7% | 133,180 | +22.9% | 0.00% | – |
| Q4 2019 | $228,000 | -25.0% | 108,391 | -21.6% | 0.00% | – |
| Q3 2019 | $304,000 | -45.6% | 138,307 | -37.3% | 0.00% | – |
| Q2 2019 | $559,000 | -42.9% | 220,714 | -21.6% | 0.00% | – |
| Q1 2019 | $979,000 | +86.5% | 281,606 | +23.9% | 0.00% | – |
| Q4 2018 | $525,000 | -36.4% | 227,200 | +5.8% | 0.00% | – |
| Q3 2018 | $826,000 | +10.4% | 214,662 | -3.2% | 0.00% | – |
| Q2 2018 | $748,000 | +154.4% | 221,663 | +58.3% | 0.00% | – |
| Q1 2018 | $294,000 | -39.6% | 140,035 | -41.8% | 0.00% | – |
| Q4 2017 | $487,000 | -43.1% | 240,558 | +29.3% | 0.00% | – |
| Q3 2017 | $856,000 | +1515.1% | 186,010 | +653.4% | 0.00% | – |
| Q2 2017 | $53,000 | -51.4% | 24,690 | -28.7% | 0.00% | – |
| Q1 2017 | $109,000 | +127.1% | 34,636 | +181.6% | 0.00% | – |
| Q3 2016 | $48,000 | -56.0% | 12,300 | -65.4% | 0.00% | – |
| Q1 2016 | $109,000 | +159.5% | 35,501 | +225.2% | 0.00% | – |
| Q4 2015 | $42,000 | -81.3% | 10,916 | -85.2% | 0.00% | – |
| Q3 2015 | $225,000 | +129.6% | 73,784 | +218.7% | 0.00% | – |
| Q2 2015 | $98,000 | -25.2% | 23,152 | +19.4% | 0.00% | – |
| Q4 2014 | $131,000 | +670.6% | 19,395 | +522.2% | 0.00% | – |
| Q3 2014 | $17,000 | -93.0% | 3,117 | -86.9% | 0.00% | – |
| Q2 2014 | $243,000 | +118.9% | 23,713 | +157.0% | 0.00% | – |
| Q1 2014 | $111,000 | – | 9,227 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,408,728 | $21,040,000 | 1.36% |
| Palo Alto Investors LP | 1,634,608 | $6,359,000 | 0.37% |
| WealthTrust Axiom LLC | 200,000 | $778,000 | 0.29% |
| Granahan Investment Management | 1,455,676 | $5,663,000 | 0.18% |
| SHEPHERD KAPLAN KROCHUK, LLC | 127,846 | $497,000 | 0.10% |
| Joel Isaacson & Co., LLC | 80,660 | $314,000 | 0.06% |
| Cornerstone Capital, Inc. | 39,700 | $154,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 281,650 | $1,096,000 | 0.02% |
| Advisor Group, Inc. | 131,992 | $513,000 | 0.01% |
| INTEGRATED WEALTH COUNSEL, LLC | 1,000 | $4,000 | 0.01% |